Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Diogene

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bulletin De L'Academie Nationale De Medecine|August 2, 2016
[Pharmacoepidemiology: lights and shadows]Joan-ramon Laporte, Eduardo Diogene
European Journal of Clinical Pharmacology|May 4, 2013
Interface management of pharmacotherapy. Joint hospital and primary care drug recommendationsLinda Björkhem-Bergman, Eva Andersén-Karlsson, Richard Laing, et al.
Basic & Clinical Pharmacology & Toxicology|July 24, 2014
Quality indicators as a tool in improving the introduction of new medicinesStephen M Campbell, Brian Godman, Eduardo Diogene, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
BMC Medicine|August 15, 2013
Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bulletin De L'Academie Nationale De Medecine|August 2, 2016
[Pharmacoepidemiology: lights and shadows]Joan-ramon Laporte, Eduardo Diogene
European Journal of Clinical Pharmacology|May 4, 2013
Interface management of pharmacotherapy. Joint hospital and primary care drug recommendationsLinda Björkhem-Bergman, Eva Andersén-Karlsson, Richard Laing, et al.
Basic & Clinical Pharmacology & Toxicology|July 24, 2014
Quality indicators as a tool in improving the introduction of new medicinesStephen M Campbell, Brian Godman, Eduardo Diogene, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
BMC Medicine|August 15, 2013
Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Pageof 1